DPT Disperse Tech

RNS Number:9072H
Disperse Technologies Group PLC
28 January 2005

                        Disperse Technologies Group plc
                            ("Disperse" or "Group")

                          VERY GOOD START TO THE YEAR

      *  Performance in line with expectations
      *  Group turnover in first quarter #6m
      *  #1.1 million VIVO sales since launch in July 2004
      *  Two new products to be launched on 1 February 2005 for Virgin Cosmetics
         Company
      *  Confident that the Group has a good future

Colston Herbert, the Executive Chairman, will make the following comments on
current trading at the Annual General Meeting to be held in London today:

"We have had a very good start to the year with the successful integration of
Elizabeth French into the Group and our performance is in line with
expectations.

Group turnover in the first quarter, which benefits from the build up to
Christmas, amounted to approximately #6 million with the results from Elizabeth
French, which was acquired in July 2004, on target. The VIVO brand which was
launched in July is developing well with sales to the end of November exceeding
#1.1 million. We are confident that we are building an excellent brand and it
has significant potential.

The traditional licensing activities of the Group continue to make good
progress. Estee Lauder introduced a new moisturiser last November, which brings
the number of products on the market using our technology to 6. Bath & Bodyworks
has continued to show its confidence in our technology by renewing the royalty
agreement. I therefore believe that we can look forward to a significant
increase in revenues from this customer in the current year.

In February this year, Virgin Cosmetics Company will be launching a range of
products which have been fully developed and sourced by Disperse Technologies.
This has enabled us to maximise the use of the skills within the Group and we
are currently negotiating a similar contract with another major company.

We operate in challenging markets, but I am confident that we have a firm base
from which to develop the Group through both organic and acquisition led growth
and that we can look forward to a good future."


For further Information:

Disperse Technologies plc
                                                                             
Colston Herbert (Executive Chairman)                         01925 215 555
Tony Williams (Finance Director)                             01925 215 555

Beattie Financial
Brian Coleman-Smith / John Moriarty / Jo Clewlow             020 7398 3300

Background Note

Group is organised into three main activity areas:

Elizabeth French
Design, importation and distribution of branded cosmetics.

Disperse - Cosmetics and Personal Care
Provision of proprietary technology and design and supply of cosmetic and
personal care products to major third party brands, such as Estee Lauder and
Bath and Body Works.

Disperse - Healthcare
The development and refining of the technology so that it can be used as a drug
delivery mechanism for oral, topical and parenteral applications.

Strategy
The Board's strategy is to integrate the Elizabeth French and Disperse -
Cosmetic and Personal Care operations and to expand Disperse pharmaceutical
activities into the more general healthcare area by the acquisition of suitable
brands or companies.

28 January 2005




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
AGMSEUFAWSISEFF

Disperse Tech (LSE:DPT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024

Disperse Tech (LSE:DPT)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024